Evidence map›Paper›PMID 32421719›Full record

ArticlePLoS neglected tropical diseases2020

Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia.

Scott D Nash, Ambahun Chernet, Jeanne Moncada, Aisha E P Stewart, Tigist Astale, Eshetu Sata, Mulat Zerihun, Demelash Gessese, Berhanu Melak, Gedefaw Ayenew and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Emergence Potential ofArchives of Razi Institute · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Forecasting Trachoma Control and Identifying Transmission-Hotspots.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Scott D NashTrachoma Control Program, The Carter Center, Atlanta, United States of America.ORCID 0000-0001-5741-8537
Ambahun ChernetTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Jeanne MoncadaDepartment of Laboratory Medicine, University of California, San Francisco, United States of America.
Aisha E P StewartTrachoma Control Program, The Carter Center, Atlanta, United States of America.
Tigist AstaleTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Eshetu SataTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Mulat ZerihunTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Demelash GesseseTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Berhanu MelakTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Gedefaw AyenewTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Zebene AyeleTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Melsew ChanyalewHealth Promotion and Disease Prevention Core Process, Amhara Regional Health Bureau, Bahir Dar, Ethiopia.
Thomas M LietmanFrancis I. Proctor Foundation, University of California, San Francisco, United States of America.
E Kelly CallahanTrachoma Control Program, The Carter Center, Atlanta, United States of America.
Julius SchachterDepartment of Laboratory Medicine, University of California, San Francisco, United States of America.
Zerihun TadesseTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
The Carter Center · ETCarter Center · USUniversity of California, San Francisco · USAmhara Regional Health Bureau · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter approximately 5 years of SAFE (surgery, antibiotics, facial cleanliness, environmental improvement) interventions for trachoma, hyperendemic (trachomatous inflammation-follicular (TF) ≥30%) districts remained in Amhara, Ethiopia. This study's aim was to characterize the epidemiology of Chlamydia trachomatis (Ct) infection and load among pre-school aged children living under the SAFE strategy.

methodsConjunctival swabs from a population-based sample of children aged 1-5 years collected between 2011 and 2015 were assayed to provide Ct infection data from 4 endemic zones (comprised of 58 districts). Ct load was determined using a calibration curve. Children were graded for TF and trachomatous inflammation-intense (TI).

results7,441 children were swabbed in 4 zones. TF and TI prevalence were 39.9% (95% confidence Interval [CI]: 37.5%, 42.4%), and 9.2% (95% CI: 8.1%, 10.3%) respectively. Ct infection prevalence was 6.0% (95% CI: 5.0%, 7.2%). Infection was highest among children aged 2 to 4 years (6.6%-7.0%). Approximately 10% of infection occurred among children aged 1 year. Ct load decreased with age (P = 0.002), with the highest loads observed in children aged 1 year (P = 0.01) vs. aged 5 years. Participants with TF (P = 0.20) and TI (P<0.01) had loads greater than individuals without active trachoma.

conclusionsIn this hyperendemic setting, it appears that the youngest children may contribute in meaningful ways towards persistent active trachoma.

Indexed as

Anti-Bacterial AgentsChild, PreschoolChlamydia trachomatisConjunctivaEndemic DiseasesEthiopiaFemaleHumansInfantMaleTrachomaAnti-Bacterial Agents

Identifiers

PMID32421719
PMCPMC7259799
OpenAlexW3028074133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.